Faithward Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Faithward Advisors’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-100	Closed	-$8K	–	255
2020 Q1	$8K	Hold	100	–	–	﹤0.01%	222
2019 Q4	$10K	Buy	+100	New	+$8.65K	﹤0.01%	228

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Faithward Advisors's XBI Position: Q2 2020 in Review

Faithward Advisors sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2020, closing a stake of 100 shares — an estimated $8K sold.

Faithward Advisors first reported a position in XBI in Q4 2019 and held it in 2 quarters. The position peaked at $10K in Q4 2019. 525 funds tracked by Wall St. Rank hold XBI as of Q2 2020.

Faithward Advisors reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2020 after selling out during the quarter.
Faithward Advisors sold 100 State Street SPDR S&P Biotech ETF shares in Q2 2020, an estimated $8K.
Faithward Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q4 2019 and held it in 2 quarters.
Faithward Advisors's State Street SPDR S&P Biotech ETF position peaked at $10K in Q4 2019.
525 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2020.

Based on Faithward Advisors's 13F filing for Q2 2020, filed 13 Aug 2020.